Form 8-K - Current report:
SEC Accession No. 0000950170-25-066939
Filing Date
2025-05-08
Accepted
2025-05-08 16:09:32
Documents
13
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20250508.htm   iXBRL 8-K 49208
2 EX-99.1 crnx-ex99_1.htm EX-99.1 133185
3 GRAPHIC img113038668_0.jpg GRAPHIC 141166
  Complete submission text file 0000950170-25-066939.txt   499381

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20250508.xsd EX-101.SCH 23893
15 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20250508_htm.xml XML 4534
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 25926104
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)